Sanger sequencing, still the standard technique for genetic testing in most diagnostic laboratories and until recently widely used in research, is gradually being complemented by next-generation sequencing (NGS). No single mutation detection technique is however perfect in identifying all mutations. Therefore, we wondered to what extent inconsistencies between Sanger sequencing and NGS affect the molecular diagnosis of patients. Since mutations in SCN1A, the major gene implicated in epilepsy, are found in the majority of Dravet syndrome (DS) patients, we focused on missed SCN1A mutations.

Pitfalls in genetic testing: the story of missed SCN1A mutations

STRIANO, PASQUALE;ZARA, FEDERICO;
2016-01-01

Abstract

Sanger sequencing, still the standard technique for genetic testing in most diagnostic laboratories and until recently widely used in research, is gradually being complemented by next-generation sequencing (NGS). No single mutation detection technique is however perfect in identifying all mutations. Therefore, we wondered to what extent inconsistencies between Sanger sequencing and NGS affect the molecular diagnosis of patients. Since mutations in SCN1A, the major gene implicated in epilepsy, are found in the majority of Dravet syndrome (DS) patients, we focused on missed SCN1A mutations.
File in questo prodotto:
File Dimensione Formato  
mgg_Djémié_SCN1A.pdf

accesso chiuso

Tipologia: Documento in versione editoriale
Dimensione 98.06 kB
Formato Adobe PDF
98.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/854833
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 54
social impact